Wadkins T S, Been M D
Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710-3711, USA.
Cell Mol Life Sci. 2002 Jan;59(1):112-25. doi: 10.1007/s00018-002-8409-7.
In the hepatitis delta virus, ribozymes are encoded in both the genomic strand RNA and its complement, the antigenomic strand. The two ribozymes are similar in sequence and structure, are most active in the presence of divalent cation and catalyze RNA cleavage reactions which generate a 5'-hydroxyl group and a 2',3'-cyclic phosphate group. Recent progress has been made in understanding the catalytic mechanism. One key was a crystal structure of the genomic ribozyme that revealed a specific cytosine positioned to act as a general acid-base catalyst. The folding of the ribozyme in the context of the longer viral RNA is another area of interest. The biology requires that each ribozyme act only once, and mechanisms proposed for regulation of ribozyme activity sometimes invoke alternative RNA structures. Likewise, interference of ribozyme function by polyadenylation of the antigenomic RNA strand could be controlled through alternative structures, and a model for such control is proposed.
在丁型肝炎病毒中,核酶编码于基因组链RNA及其互补链(反基因组链)中。这两种核酶在序列和结构上相似,在二价阳离子存在时活性最强,并催化RNA切割反应,生成一个5'-羟基基团和一个2',3'-环磷酸基团。在理解催化机制方面最近取得了进展。一个关键是基因组核酶的晶体结构,它揭示了一个特定的胞嘧啶,其位置可作为一般酸碱催化剂。核酶在较长病毒RNA背景下的折叠是另一个有趣的领域。生物学要求每个核酶仅作用一次,为调节核酶活性而提出的机制有时会涉及替代RNA结构。同样,反基因组RNA链的聚腺苷酸化对核酶功能的干扰可通过替代结构来控制,并提出了这样一种控制模型。